Cited by 589Prion Diseases and Protein MisfoldingEndoplasmic Reticulum Stress and DiseaseAlzheimer's disease research and treatments

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Oral Treatment Targeting the Unfolded Protein Response Prevents Neurodegeneration and Clinical Disease in Prion-Infected Mice

Moreno, Julie A., Halliday, Mark, Molloy, Colin, Radford, Helois, Verity, Nicholas, Axten, Jeffrey M., Ortori, Catharine A., Willis, Anne E., Fischer, Peter M., Barrett, David A., Mallucci, Giovanna R.·2013·Science Translational Medicine

DOI 10.1126/scitranslmed.3006767

Open this paper in CoChat — free account

Abstract

During prion disease, an increase in misfolded prion protein (PrP) generated by prion replication leads to sustained overactivation of the branch of the unfolded protein response (UPR) that controls the initiation of protein synthesis. This results in persistent repression of translation, resulting in the loss of critical proteins that leads to synaptic failure and neuronal death. We have previously reported that localized genetic manipulation of this pathway rescues shutdown of translation and prevents neurodegeneration in a mouse model of prion disease, suggesting that pharmacological inhibition of this pathway might be of therapeutic benefit. We show that oral treatment with a specific inhibitor of the kinase PERK (protein kinase RNA-like endoplasmic reticulum kinase), a key mediator of this UPR pathway, prevented UPR-mediated translational repression and abrogated development of clinical prion disease in mice, with neuroprotection observed throughout the mouse brain. This was the case for animals treated both at the preclinical stage and also later in disease when behavioral signs had emerged. Critically, the compound acts downstream and independently of the primary pathogenic process of prion replication and is effective despite continuing accumulation of misfolded PrP. These data suggest that PERK, and other members of this pathway, may be new therapeutic targets for developing drugs against prion disease or other neurodegenerative diseases where the UPR has been implicated.

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.3006767

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

RETRACTED: Endoplasmic reticulum stress and induction of the unfolded protein response in human sporadic amyotrophic lateral sclerosis
Atkin, J. D., Farg, M. A., Walker, A. K., McLean, C., Tomas, D., & Horne, M. K. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.02.009 · Cited by 350
Retracted
Signal integration in the endoplasmic reticulum unfolded protein response
Ron, D., & Walter, P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2199 · Cited by 6,431
Regulated Translation Initiation Controls Stress-Induced Gene Expression in Mammalian Cells
Harding, H. P., Novoa, I., Zhang, Y., Zeng, H., Wek, R. C., Schapira, M., & Ron, D. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00108-8 · Cited by 3,344
Adapting Proteostasis for Disease Intervention
Balch, W. E., Morimoto, R. I., Dillin, A., & Kelly, J. W. (2008) · Science · doi:10.1126/science.1141448 · Cited by 2,495
Diabetes Mellitus and Exocrine Pancreatic Dysfunction in Perk−/− Mice Reveals a Role for Translational Control in Secretory Cell Survival
Harding, H. P., Zeng, H., Zhang, Y., Jungries, R., Chung, P., Plesken, H., Sabatini, D. D., & Ron, D. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00264-7 · Cited by 1,217
Depleting Neuronal PrP in Prion Infection Prevents Disease and Reverses Spongiosis
Mallucci, G. R., Dickinson, A., Linehan, J. M., Klöhn, P., Brandner, S., & Collinge, J. (2003) · Science · doi:10.1126/science.1090187 · Cited by 783
Self-citation
Translational Regulation of Gene Expression during Conditions of Cell Stress
Spriggs, K. A., Bushell, M., & Willis, A. E. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.028 · Cited by 748
Self-citation
Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1 H -indol-5-yl)-7 H -pyrrolo[2,3- d ]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK)
Axten, J. M., Medina, J. R., Feng, Y., Shu, A. Y. L., Romeril, S. P., Grant, S. W., Li, W. H. H., Heerding, D. A., Minthorn, E. A., Mencken, T., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300713s · Cited by 620
Self-citation
Sustained translational repression by eIF2α-P mediates prion neurodegeneration
Moreno, J. A., Radford, H. E., Peretti, D., Steinert, J. R., Verity, N., Martin, M. G., Halliday, M., Morgan, J., Dinsdale, D. D., Ortori, C. A., et al. (2012) · Nature · doi:10.1038/nature11058 · Cited by 616
Self-citation
The Unfolded Protein Response Is Activated in Pretangle Neurons in Alzheimer's Disease Hippocampus
Hoozemans, J. J. M., van Haastert, E. S., Nijholt, D. A. T., Rozemuller, A. J. M., Eikelenboom, P., & Scheper, W. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080814 · Cited by 600

Show all 29 references

Sorted by citations

Items 201–300 of 582

Inhibition of group-I metabotropic glutamate receptors protects against prion toxicity
Goniotaki, D., Lakkaraju, A. K., Shrivastava, A. N., Bakirci, P., Sorce, S., Senatore, A., Marpakwar, R., Hornemann, S., Gasparini, F., Triller, A., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006733 · Cited by 52
PERK inhibition delays neurodegeneration and improves motor function in a mouse model of Marinesco-Sjögren syndrome
Grande, V., Ornaghi, F., Comerio, L., Restelli, E., Masone, A., Corbelli, A., Tolomeo, D., Capone, V., Axten, J. M., Laping, N. J., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy152 · Cited by 50
Self-citation
Lost in Translation: Evidence for Protein Synthesis Deficits in ALS/FTD and Related Neurodegenerative Diseases
Lehmkuhl, E. M., & Zarnescu, D. C. (2018) · Advances in neurobiology · doi:10.1007/978-3-319-89689-2_11 · Cited by 51
Alzheimer’s therapy targeting the β-secretase enzyme BACE1: Benefits and potential limitations from the perspective of animal model studies
Ohno, M. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.04.007 · Cited by 51
Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress
Masciarelli, S., Capuano, E., Ottone, T., Divona, M., Panfilis, S. D., Banella, C., Noguera, N. I., Picardi, A., Fontemaggi, G., Blandino, G., et al. (2017) · Leukemia · doi:10.1038/leu.2017.231 · Cited by 49
eIF2B and the Integrated Stress Response: A Structural and Mechanistic View
Marintchev, A., & Ito, T. (2020) · Biochemistry · doi:10.1021/acs.biochem.0c00132 · Cited by 48
Brain-specific suppression of AMPKα2 isoform impairs cognition and hippocampal LTP by PERK-mediated eIF2α phosphorylation
Yang, W., Zhou, X., Zimmermann, H. R., & Ma, T. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0739-z · Cited by 48
CDNF rescues motor neurons in models of amyotrophic lateral sclerosis by targeting endoplasmic reticulum stress
Lorenzo, F. D., Lüningschrör, P., Nam, J. H., Beckett, L., Pilotto, F., Galli, E., Lindholm, P., von Collenberg, C. R., Mungwa, S. T., Jablonka, S., et al. (2023) · Brain · doi:10.1093/brain/awad087 · Cited by 47
Prion degradation pathways: Potential for therapeutic intervention
Goold, R., McKinnon, C., & Tabrizi, S. J. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2014.12.009 · Cited by 51
Hypothermic Preconditioning of Human Cortical Neurons Requires Proteostatic Priming
Rzechorzek, N. M., Connick, P., Patani, R., Selvaraj, B. T., & Chandran, S. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.04.004 · Cited by 47
A direct method for detecting proteins in body fluids by Surface-Enhanced Raman Spectroscopy under native conditions
Li, D., Zhang, Z., Wang, X., Wang, Y., Gao, X. Q., & Li, Y. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113907 · Cited by 47
Combating neurodegenerative disease with chemical probes and model systems
Narayan, P. S., Ehsani, S., & Lindquist, S. L. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1663 · Cited by 47
How do PrPSc Prions Spread between Host Species, and within Hosts?
Mabbott, N. A. (2017) · Pathogens · doi:10.3390/pathogens6040060 · Cited by 46
Interplay Between the Unfolded Protein Response and Immune Function in the Development of Neurodegenerative Diseases
García-González, P. A., Cabral‐Miranda, F., Hetz, C. A., & Osorio, F. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02541 · Cited by 46
Memory loss in Alzheimer's disease: are the alterations in the UPR network involved in the cognitive impairment?
Duran-Aniotz, C. A., Martínez, G., & Hetz, C. A. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00008 · Cited by 46
Targeting of the unfolded protein response (UPR) as therapy for Parkinson's disease
Martinez, A. N., López, N., González, C., & Hetz, C. A. (2019) · Biology of the Cell · doi:10.1111/boc.201800068 · Cited by 45
Chronic PERK induction promotes Alzheimer-like neuropathology in Down syndrome: Insights for therapeutic intervention
Lanzillotta, C., Zuliani, I., Tramutola, A., Barone, E., Blarzino, C., Folgiero, V., Caforio, M., Valentini, D., Villani, A., Locatelli, F., et al. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101892 · Cited by 46
Loss of PIKfyve drives the spongiform degeneration in prion diseases
Lakkaraju, A. K., Frontzek, K., Lemes, E., Herrmann, U., Losa, M., Marpakwar, R., & Aguzzi, A. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202114714 · Cited by 44
Calcium Ions Aggravate Alzheimer’s Disease Through the Aberrant Activation of Neuronal Networks, Leading to Synaptic and Cognitive Deficits
Guan, P.-P., Cao, L., Yang, Y., & Wang, P. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.757515 · Cited by 47
Assessment of common variability and expression quantitative trait loci for genome-wide associations for progressive supranuclear palsy
Ferrari, R., Ryten, M., Simone, R., Trabzuni, D., Nicolaou, N., Hondhamuni, G., Ramasamy, A., Vandrovcová, J., Weale, M. E., Lees, A. J., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.010 · Cited by 44
PERK Pathway Activation Promotes Intracerebral Hemorrhage Induced Secondary Brain Injury by Inducing Neuronal Apoptosis Both in Vivo and in Vitro
Meng, C., Zhang, J., Dang, B., Li, H., Shen, H., Li, X., & Wang, Z. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00111 · Cited by 43
Unfolded Protein Response as a Therapeutic Target in Cardiovascular Disease
Zhang, G., Wang, X., Gillette, T. G., Deng, Y., & Wang, Z. V. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190521093049 · Cited by 43
Intra‐axonal protein synthesis in development and beyond
Batista, A. F. R., & Hengst, U. (2016) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2016.03.004 · Cited by 45
Translational control by eIF2α in neurons: Beyond the stress response
Bellato, H. M., & Hajj, G. N. M. (2016) · Cytoskeleton · doi:10.1002/cm.21294 · Cited by 46
ER Stress and Neurodegenerative Disease: A Cause or Effect Relationship?
Cabral‐Miranda, F., & Hetz, C. A. (2017) · Current topics in microbiology and immunology · doi:10.1007/82_2017_52 · Cited by 46
Brain penetrant kinase inhibitors: Learning from kinase neuroscience discovery
Shi, Y., & Mader, M. M. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.05.007 · Cited by 42
Evidence for eIF2α phosphorylation-independent effects of GSK2656157, a novel catalytic inhibitor of PERK with clinical implications
Krishnamoorthy, J., Rajesh, K., Mirzajani, F., Kesoglidou, P.-X., Papadakis, A. I., & Koromilas, A. E. (2014) · Cell Cycle · doi:10.4161/cc.27726 · Cited by 43
The Chaperone Grp78 in Protein Folding Disorders of the Nervous System
Moreno, J. A., & Tiffany‐Castiglioni, E. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1405-0 · Cited by 41
Self-citation
Cellular models for discovering prion disease therapeutics: Progress and challenges
Krance, S. H., Luke, R., Shenouda, M., Israwi, A. R., Colpitts, S. J., Darwish, L., Strauss, M. T., & Watts, J. C. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14956 · Cited by 46
Staufen 1 amplifies proapoptotic activation of the unfolded protein response
Gandelman, M., Dansithong, W., Figueroa, K. P., Paul, S., Scoles, D. R., & Pulst, S. M. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0553-9 · Cited by 41
Endoplasmic Reticulum Stress in Biological Processing and Disease
Köksal, A. R., Verne, G. N., & Zhou, Q. (2021) · Journal of Investigative Medicine · doi:10.1136/jim-2020-001570 · Cited by 41
Quantitative EEG parameters correlate with the progression of human prion diseases
Frankó, E., Wehner, T., Joly, O., Lowe, J., Porter, M., Kenny, J., Thompson, A. G. B., Rudge, P., Collinge, J., & Mead, S. (2016) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-313501 · Cited by 40
RGC-specific ATF4 and/or CHOP deletion rescues glaucomatous neurodegeneration and visual function
Fang, F., Liu, P., Huang, H., Feng, X., Li, L., Sun, Y., Kaufman, R. J., & Hu, Y. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.07.015 · Cited by 42
Unfolded Protein Response and Macroautophagy in Alzheimer’s, Parkinson’s and Prion Diseases
Milisav, I., Šuput, D., & Ribarič, S. (2015) · Molecules · doi:10.3390/molecules201219865 · Cited by 42
Regulation of MicroRNAs-Mediated Autophagic Flux: A New Regulatory Avenue for Neurodegenerative Diseases With Focus on Prion Diseases
Shah, S. Z. A., Zhao, D., Hussain, T. A., Sabir, N., & Yang, L. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00139 · Cited by 41
Crosstalk between the Unfolded Protein Response and NF- κ B-Mediated Inflammation in the Progression of Chronic Kidney Disease
Mohammed‐Ali, Z., Cruz, G. L., & Dickhout, J. G. (2015) · Journal of Immunology Research · doi:10.1155/2015/428508 · Cited by 40
Activation of EP2 receptor suppresses poly(I: C) and LPS‐mediated inflammation in primary microglia and organotypic hippocampal slice cultures: Contributing role for MAPKs
Yousif, N. M., de Oliveira, A. C. P., Brioschi, S., Hüell, M., Biber, K. P. H., & Fiebich, B. L. (2017) · Glia · doi:10.1002/glia.23276 · Cited by 40
Inhibiting ER Stress Weakens Neuronal Pyroptosis in a Mouse Acute Hemorrhagic Stroke Model
Chen, G., Gao, C. H., Yan, Y., Wang, T., Luo, C., Zhang, M., Chen, X., & Tao, L. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02097-9 · Cited by 39
Research progress on human genes involved in the pathogenesis of glaucoma (Review)
Wang, H., Sun, P., Chen, Y., Jiang, L., Wu, H., Zhang, W., & Gao, F. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9071 · Cited by 38
The Unfolded Protein Response: A Key Player in Zika Virus-Associated Congenital Microcephaly
Alfano, C., Gladwyn-Ng, I. E., Couderc, T., Lecuit, M., & Nguyen, L. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00094 · Cited by 38
IRE1α RIDD activity induced under ER stress drives neuronal death by the degradation of 14-3-3 θ mRNA in cortical neurons during glucose deprivation
Gómora‐García, J. C., Gerónimo‐Olvera, C., Pérez-Martínez, X., & Massieu, L. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00518-9 · Cited by 39
Targeting Axonal Protein Synthesis in Neuroregeneration and Degeneration
Baleriola, J., & Hengst, U. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0308-8 · Cited by 38
ER Stress, CREB, and Memory: A Tangled Emerging Link in Disease
Sen, N. (2018) · The Neuroscientist · doi:10.1177/1073858418816611 · Cited by 37
The PPP1R15 Family of eIF2-alpha Phosphatase Targeting Subunits (GADD34 and CReP)
Hicks, D., Giresh, K., Wrischnik, L. A., & Weiser, D. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417321 · Cited by 41
Inhibition of PERK-mediated unfolded protein response acts as a switch for reversal of residual senescence and as senolytic therapy in glioblastoma
Ketkar, M., Desai, S., Rana, P., Thorat, R. A., Epari, S., Dutt, A., & Dutt, S. (2024) · Neuro-Oncology · doi:10.1093/neuonc/noae134 · Cited by 37
HIV Protease Inhibitors Alter Amyloid Precursor Protein Processing via β-Site Amyloid Precursor Protein Cleaving Enzyme-1 Translational Up-Regulation
Gannon, P. J., Akay, C., Yee, A. C., Briand, L. A., Erickson, M. A., Gelman, B. B., Gao, Y., Haughey, N. J., Zink, M. C., Clements, J. E., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.09.006 · Cited by 36
The Role of Unfolded Protein Response and Mitogen-Activated Protein Kinase Signaling in Neurodegenerative Diseases with Special Focus on Prion Diseases
Shah, S. Z. A., Zhao, D., Hussain, T. A., & Yang, L. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00120 · Cited by 36
PERK inhibitor, GSK2606414, ameliorates neuropathological damage, memory and motor functional impairments in cerebral ischemia via PERK/p-eIF2ɑ/ATF4/CHOP signaling
Dhir, N., Jain, A., Sharma, A. R., Prakash, A., Radotra, B., & Medhi, B. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01183-w · Cited by 38
Human prion diseases and the prion protein – what is the current state of knowledge?
Nafe, R., Arendt, C. T., & Hattingen, E. (2023) · Translational Neuroscience · doi:10.1515/tnsci-2022-0315 · Cited by 36
ER stress signaling and neurodegeneration: At the intersection between Alzheimer's disease and Prion-related disorders
Torres, M., Matamala, J. M., Duran-Aniotz, C. A., Cornejo, V. H., Foley, A., & Hetz, C. A. (2014) · Virus Research · doi:10.1016/j.virusres.2014.12.018 · Cited by 39
Immunoregulation of the decidualization program: focus on the endoplasmic reticulum stress
Soczewski, E., Grasso, E., Gallino, L., Hauk, V. C., Fernández, L., Gori, S., Paparini, D., Leirós, C. P., & Ramhorst, R. (2020) · Reproduction · doi:10.1530/rep-19-0391 · Cited by 35
PERK: a novel therapeutic target for neurodegenerative diseases?
Ma, T., & Klann, E. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt260 · Cited by 35
Diabetes mellitus and the key role of endoplasmic reticulum stress in pancreatic β cells
Lytrivi, M., Tong, Y. A., Virgilio, E., Yi, X., & Cnop, M. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01129-5 · Cited by 36
Control of mRNA Translation in ALS Proteinopathy
Cestra, G., Rossi, S., Salvio, M. D., & Cozzolino, M. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00085 · Cited by 36
Targeting Protein Synthesis in Colorectal Cancer
Schmidt, S., Denk, S., & Wiegering, A. (2020) · Cancers · doi:10.3390/cancers12051298 · Cited by 36
Translation Regulation by eIF2α Phosphorylation and mTORC1 Signaling Pathways in Non-Communicable Diseases (NCDs)
Rios-Fuller, T. J., Mahé, M., Walters, B., Abbadi, D., Pérez-Baos, S., Gadi, A., Andrews, J. J., Katsara, O., Vincent, C. T., & Schneider, R. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155301 · Cited by 34
Ghrelin protects dopaminergic neurons against MPTP neurotoxicity through promoting autophagy and inhibiting endoplasmic reticulum mediated apoptosis
Wang, H., Dou, S., Zhu, J., Shao, Z., Wang, C., & Cheng, B. (2020) · Brain Research · doi:10.1016/j.brainres.2020.147023 · Cited by 33
PrPC signalling in neurons: From basics to clinical challenges
Hirsch, T. Z., Hernandez-Rapp, J., Martin‐Lannerée, S., Launay, J., & Mouillet‐Richard, S. (2014) · Biochimie · doi:10.1016/j.biochi.2014.06.009 · Cited by 37
Prion disease is accelerated in mice lacking stress-induced heat shock protein 70 (HSP70)
Mays, C. E., Armijo, E., Morales, R., Kramm, C., Flores, A., Tiwari, A., Bian, J., Telling, G. C., Pandita, T. K., Hunt, C. R., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006186 · Cited by 33
Evolutionarily Conserved Regulation of Sleep by the Protein Translational Regulator PERK
Ly, S., Lee, D. A., Strus, E., Prober, D. A., & Naidoo, N. N. (2020) · Current Biology · doi:10.1016/j.cub.2020.02.030 · Cited by 34
APOE4 Affects Basal and NMDAR-Mediated Protein Synthesis in Neurons by Perturbing Calcium Homeostasis
Ramakrishna, S., Jhaveri, V., Konings, S. C., Nawalpuri, B., Chakraborty, S., Holst, B., Schmid, B., Gouras, G. K., Freude, K., & Muddashetty, R. S. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.0435-21.2021 · Cited by 34
Prion disease
Takada, L. T., Kim, M., Metcalf, S., Illán‐Gala, I., & Geschwind, M. D. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64076-5.00029-6 · Cited by 34
Ablation of Perk in Schwann Cells Improves Myelination in the S63del Charcot-Marie-Tooth 1B Mouse
Sidoli, M., Musner, N., Silvestri, N., Ungaro, D., D’Antonio, M., Cavener, D., Feltri, M., & Wrabetz, L. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1637-16.2016 · Cited by 29
Comparison of the Anti-Prion Mechanism of Four Different Anti-Prion Compounds, Anti-PrP Monoclonal Antibody 44B1, Pentosan Polysulfate, Chlorpromazine, and U18666A, in Prion-Infected Mouse Neuroblastoma Cells
Yamasaki, T., Suzuki, A., Hasebe, R., & Horiuchi, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106516 · Cited by 32
The stress of prion disease
Mays, C. E., & Soto, C. A. (2016) · Brain Research · doi:10.1016/j.brainres.2016.04.009 · Cited by 32
Acinar cell injury induced by inadequate unfolded protein response in acute pancreatitis
Barrera, K., Stanek, A., Okochi, K., Niewiadomska, Z., Mueller, C. M., Ou, P., John, D. G., Alfonso, A. E., Tenner, S. M., & Huan, C. (2018) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v9.i2.37 · Cited by 32
Roles and Mechanisms of the Protein Quality Control System in Alzheimer’s Disease
Liu, Y., Ding, R., Xu, Z., Xue, Y., Zhang, D., Zhang, Y., Li, W., & Li, X. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010345 · Cited by 32
Endoplasmic Reticulum Stress and Dysregulated Autophagy in Human Pancreatic Beta Cells
Moon, S., & Jung, H. S. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2022.0070 · Cited by 32
Pharmacological Targeting of Endoplasmic Reticulum Stress in Pancreatic Beta Cells
Bilekova, S., Sachs, S., & Lickert, H. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.11.011 · Cited by 31
Neuron‐specific translational control shift ensures proteostatic resilience during ER stress
Wolzak, K., Nölle, A., Farina, M., Abbink, T. E. M., van der Knaap, M. S., Verhage, M., & Scheper, W. (2022) · The EMBO Journal · doi:10.15252/embj.2021110501 · Cited by 31
Mechanisms of prion-induced toxicity
Mercer, R. C. C., & Harris, D. A. (2022) · Cell and Tissue Research · doi:10.1007/s00441-022-03683-0 · Cited by 32
Successes and Challenges in Phenotype-Based Lead Discovery for Prion Diseases
Ghaemmaghami, S., Russo, M. M., & Renslo, A. R. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5001425 · Cited by 31
Parkinson's disease as a member of Prion-like disorders
Herva, M. E., & Spillantini, M. G. (2014) · Virus Research · doi:10.1016/j.virusres.2014.10.016 · Cited by 33
Insights into the Architecture of the eIF2Bα/β/δ Regulatory Subcomplex
Bogorad, A. M., Xia, B., Sandor, D. G., Mamonov, A. B., Cafarella, T. M., Jehle, S., Vajda, S., Kozakov, D., & Marintchev, A. (2014) · Biochemistry · doi:10.1021/bi500346u · Cited by 31
Isochaihulactone-induced DDIT3 causes ER stress-PERK independent apoptosis in glioblastoma multiforme cells
Tsai, S., Tao, M., Ho, L.-I., Chiou, T., Lin, S., Su, H.-L., & Harn, H. (2016) · Oncotarget · doi:10.18632/oncotarget.13266 · Cited by 31
Neuroprotective Effects of Protein Tyrosine Phosphatase 1B Inhibition against ER Stress-Induced Toxicity
Jeon, Y., Lee, S., Kim, S., Kwon, Y., Kim, K., Chung, C. G., Lee, S., Lee, S. B., & Kim, H. (2017) · Molecules and Cells · doi:10.14348/molcells.2017.2320 · Cited by 31
Neurite atrophy and apoptosis mediated by PERK signaling after accumulation of GM2-ganglioside
Virgolini, M. J., Feliziani, C., Cambiasso, M. J., López, P. H. H., & Bollo, M. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.10.014 · Cited by 31
Molecular modeling provides a structural basis for PERK inhibitor selectivity towards RIPK1
Chintha, C., Carlesso, A., Gorman, A. M., Afshin Samali, A., & Eriksson, L. A. (2020) · RSC Advances · doi:10.1039/c9ra08047c · Cited by 31
Protein kinase R(PKR)–like endoplasmic reticulum kinase (PERK) inhibitors: a patent review (2010-2015)
Axten, J. M. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2017.1238072 · Cited by 30
Self-citation
Cell-based HTS identifies a chemical chaperone for preventing ER protein aggregation and proteotoxicity
Kitakaze, K., Taniuchi, S., Kawano, E., Hamada, Y., Miyake, M., Oyadomari, M., Kojima, H., Kosako, H., Kuribara, T., Yoshida, S., et al. (2019) · eLife · doi:10.7554/elife.43302 · Cited by 30
The Role and Therapeutic Potential of the Integrated Stress Response in Amyotrophic Lateral Sclerosis
Marlin, E., Viu-Idocin, C., Arrasate, M., & Aragón, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147823 · Cited by 32
Messenger RNA Translation Defects in Neurodegenerative Diseases
Storkebaum, E., Rosenblum, K., & Sonenberg, N. (2023) · New England Journal of Medicine · doi:10.1056/nejmra2215795 · Cited by 32
Mechanisms and models of endoplasmic reticulum stress in chondrodysplasia
Patterson, S. E., & Dealy, C. N. (2014) · Developmental Dynamics · doi:10.1002/dvdy.24131 · Cited by 30
Specific PERK inhibitors enhanced glucose-stimulated insulin secretion in a mouse model of type 2 diabetes
Kim, M. J., Kim, M., Min, S. H., Ham, D., Kim, J., Yoon, K., Park, K. S., & Jung, H. S. (2019) · Metabolism · doi:10.1016/j.metabol.2018.12.007 · Cited by 30
Chaperone-Mediated Autophagy in the Liver: Good or Bad?
Dash, S., Aydın, Y., & Moroz, K. (2019) · Cells · doi:10.3390/cells8111308 · Cited by 32
Immunotherapy against Prion Disease
Ma, Y., & Ma, J. (2020) · Pathogens · doi:10.3390/pathogens9030216 · Cited by 31
Proteostasis Deregulation in Neurodegeneration and Its Link with Stress Granules: Focus on the Scaffold and Ribosomal Protein RACK1
Masi, M., Attanzio, A., Racchi, M., Wolozin, B. L., Borella, S., Biundo, F., & Buoso, E. (2022) · Cells · doi:10.3390/cells11162590 · Cited by 31
The integrated stress response in brain diseases: A double-edged sword for proteostasis and synapses
Lockshin, E. R., & Calakos, N. (2024) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2024.102886 · Cited by 31
Calcineurin β protects brain after injury by activating the unfolded protein response
Chen, Y., Holstein, D. M., Aime, S., Bollo, M., & Lechleiter, J. D. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.06.011 · Cited by 29
What Is Our Current Understanding of PrPSc-Associated Neurotoxicity and Its Molecular Underpinnings?
Hughes, D., & Halliday, M. (2017) · Pathogens · doi:10.3390/pathogens6040063 · Cited by 33
Self-citation
Mechanisms of disordered neurodegenerative function: concepts and facts about the different roles of the protein kinase RNA-like endoplasmic reticulum kinase (PERK)
Taalab, Y. M., Ibrahim, N., Maher, A., Hassan, M., Mohamed, W. M. Y., Moustafa, A. A., Salama, M., Johar, D., & Bernstein, L. H. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0071 · Cited by 30
Unravelling protein aggregation as an ageing related process or a neuropathological response
Trigo, D., Nadais, A., & Silva, O. A. B. D. C. E. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.02.001 · Cited by 31
microRNAs in Cardiovascular Disease: Small Molecules but Big Roles
Yan, B., Wang, H., Tan, Y., & Fu, W. E. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190808160241 · Cited by 29
The role of eIF2 phosphorylation in cell and organismal physiology: new roles for well-known actors
Wang, X., & Proud, C. G. (2022) · Biochemical Journal · doi:10.1042/bcj20220068 · Cited by 29
Trazodone rescues dysregulated synaptic and mitochondrial nascent proteomes in prion neurodegeneration
Albert‐Gascó, H., Smith, H., Alvarez‐Castelao, B., Swinden, D., Halliday, M., Janaki‐Raman, S., Butcher, A. J., & Mallucci, G. R. (2023) · Brain · doi:10.1093/brain/awad313 · Cited by 30
Self-citation
Replicated, replicable and relevant–target engagement and pharmacological experimentation in the 21st century
Kenakin, T., Bylund, D. B., Toews, M. L., Mullane, K., Winquist, R. J., & Williams, M. J. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.10.024 · Cited by 28
Modulation of Endoplasmic Reticulum Stress: An Opportunity to Prevent Neurodegeneration?
Plácido, A. I., Pereira, C., Duarte, A. I., Candeias, E., Correia, S. C., Carvalho, C., Cardoso, S., Oliveira, C. R., & Moreira, P. I. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527314666150429112353 · Cited by 28
Cardioprotection Afforded by Sour Cherry Seed Kernel
Czompa, A., Gyöngyösi, A., Czeglédi, A., Csépányi, E., Bak, I., Haines, D. D., Tósaki, Á., & Lekli, I. (2014) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000132 · Cited by 28
Treatment with a non-toxic, self-replicating anti-prion delays or prevents prion disease in vivo
Díaz‐Espinoza, R., Morales, R., Concha‐Marambio, L., Moreno‐González, I., Moda, F., & Soto, C. A. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.84 · Cited by 28
PERK Regulates Working Memory and Protein Synthesis-Dependent Memory Flexibility
Zhu, S., Henninger, K., McGrath, B. C., & Cavener, D. R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162766 · Cited by 29

Authors: Moreno, J. A., Halliday, M., Molloy, C., Radford, H., Verity, N., Axten, J. M., Ortori, C. A., Willis, A. E., Fischer, P. M., Barrett, D. A., & Mallucci, G. R.
Affiliations: University of Leicester (GB)
GlaxoSmithKline (United States) (US)
University of Nottingham (GB)
Corresponding author: Mallucci, Giovanna R.
ORCID: Moreno, Julie A.
Molloy, Colin
Radford, Helois
Axten, Jeffrey M.
Willis, Anne E.
Fischer, Peter M.
Barrett, David A.
Mallucci, Giovanna R.
Venue: Science Translational Medicine
Publisher: American Association for the Advancement of Science (AAAS)
Published: 2013-10-09
Volume: 5
Issue: 206
Pages: 206ra138-206ra138
ISSN: 1946-6234 (ISSN-L)
1946-6242
DOI: 10.1126/scitranslmed.3006767
OpenAlex: W2010375635
Cited by: 589
References: 29
Citations by year: 2026: 22 · 2025: 27 · 2024: 21 · 2023: 29 · 2022: 32 · 2021: 42 · 2020: 59 · 2019: 46 · 2018: 54 · 2017: 72 · 2016: 54 · 2015: 58 · 2014: 58 · 2013: 13
FWCI: 27.31
Type: journal article
Language: en
Open access: closed
Locations: Science Translational Medicine (publishedVersion)
PubMed (publishedVersion)
Leicester Research Archive (University of Leicester) (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords: prion disease, unfolded protein response, protein synthesis inhibition, neurodegeneration, oral drug therapy, neuroprotection, prion replication, synaptic failure, neurodegenerative disease treatment
MeSH terms: Adenine, Administration, Oral, Animals, Blood-Brain Barrier, Brain, Indoles, Nerve Degeneration, Phosphorylation, Prions, Synapses, Protein Biosynthesis, Eukaryotic Initiation Factor-2, Prion Diseases, Neuroprotective Agents, eIF-2 Kinase, Mice, Unfolded Protein Response

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Oral Treatment Targeting the Unfolded Protein Response Prevents Neurodegeneration and Clinical Disease in Prion-Infected Mice

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks